MENU
HYPD
AS OF
Dec 24 closing price
Price
$4.02
Change
+$0.27 (+7.20%)
Capitalization
32.85M
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
HYPD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Hyperion DeFi (HYPD) Ownership - Who owns Hyperion DeFi?

Eyenovia Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
32.85M
P/E Ratio
N/A
Total Cash
8.22M
Projected Growth
N/A
Total Debt
8.49M
Revenue
345.32K
Risk (Beta)
5.42
Dividend Yield
N/A
Total Cash/Share
1.01
Total Debt/Equity
N/A
Revenue/Share
0.11 USD as % of share price

Fundamentals

HYPD
Capitalization
32.9M
P/E Ratio
N/A
Risk (Beta)
5.42
Dividend Yield
N/A
Total Cash
8.22M
Total Cash/Share
1.01
Total Debt
8.49M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.11%
Revenue
345K
ROE
N/A
Book Value
70.8M
P/B Ratio
0.46
Cash Flow
N/A
Earnings
-19.15
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
715
Current Ratio
2.25
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-23.34M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-50.00
Shares Held By Institutions
7.09M
Shares Outstanding - Current
8.17M
Total Liabilities
12M
Total Volume MTD
N/A
Value
1
Gain YTD
2653.425
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
HYPD
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
View AI-Driven Trading for HYPD
A.I. Advisor
published General Information

General Information

a company which delivers sight saving therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A